Recursion Pharmaceuticals, Inc. RXRX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s asset turnover?
- Recursion Pharmaceuticals, Inc. (RXRX) reported asset turnover of 0.1× in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s asset turnover changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s asset turnover decreased by 21.8% year-over-year, from 0.1× to 0.1×.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s asset turnover?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s asset turnover has grown at a 22.9% compound annual growth rate (CAGR), from 0× to 0.1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.